Teleflex Valuation Multiples

Teleflex Overview

About Teleflex

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.

Founded

1943

HQ

Employees

14.1K

Website

teleflex.com

Sectors

Medical DevicesDeepTechHealthTech

Financials (LTM)

Revenue: $2B

EBITDA: $591M

EV

$8B

Valuation Multiples

Multiples.vc

Start free trial

Teleflex Financials

Teleflex reported last 12-month revenue of $2B and EBITDA of $591M.

In the same LTM period, Teleflex generated $1B in gross profit, $591M in EBITDA, and $307M in net income.

Teleflex P&L

In the most recent fiscal year, Teleflex reported revenue of $2B and EBITDA of $609M.

Teleflex expects next 12-month revenue of XXX and NTM EBITDA of XXX

Teleflex Stock Performance

Teleflex has current market cap of $6B, and enterprise value of $8B.

Teleflex's stock price is $131.58.

Teleflex Valuation Multiples

Teleflex trades at 3.9x EV/Revenue multiple, and 13.8x EV/EBITDA.

Teleflex Financial Valuation Multiples

As of April 20, 2026, Teleflex has market cap of $6B and EV of $8B.

Equity research analysts estimate Teleflex's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Teleflex has a P/E ratio of 19.0x.

Teleflex Margins & Growth Rates

Teleflex's revenue in the last 12 month grew by 12%.

Teleflex's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.

Teleflex's rule of 40 is 39% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Teleflex's rule of X is 61% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Teleflex Public Comps

See public comps and valuation multiples for other Medical Devices comps.

Teleflex M&A Activity

Teleflex acquired XXX companies to date.

Last acquisition by Teleflex was on XXXXXXXX, XXXXX. Teleflex acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Teleflex Investment Activity

Teleflex invested in XXX companies to date.

Teleflex made its latest investment on XXXXXXXX, XXXXX. Teleflex invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).